Entresto — Medical Mutual
Heart Failure (HF), Pediatric Patients – initial therapy
Initial criteria
- The patient is ≥ 1 year of age; AND
- Entresto is being used for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction; AND
- Prescribed by or in consultation with a cardiologist; AND
- Entresto will not be used concomitantly with ACE inhibitors, ARBs, or with aliskiren (Tekturna) in patients with diabetes; AND
- The dose of Entresto will not exceed 97/103 mg twice daily
Approval duration
1 year